Handelsbanken Fonder Ab Vertex Pharmaceuticals Inc Transaction History

Handelsbanken Fonder Ab

$25.3 Billion
Q3 2024

A detailed history of Handelsbanken Fonder Ab transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Handelsbanken Fonder Ab holds 411,515 shares of VRTX stock, worth $207 Million. This represents 0.76% of its overall portfolio holdings.

Number of Shares

411,515

Previous 416,381 1.17%

Holding current value

$207 Million

Previous $195 Million 1.94%

% of portfolio

0.76%

Previous 0.85%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 04, 2024	SELL	$460.0 - $505.78 $2.24 Million - $2.46 Million	-4,866 Reduced 1.17%	411,515 $191 Million
Q2 2024 Aug 05, 2024	BUY	$392.81 - $485.53 $57.2 Million - $70.7 Million	145,696 Added 53.82%	416,381 $195 Million
Q1 2024 May 13, 2024	BUY	$407.69 - $446.08 $4.24 Million - $4.64 Million	10,412 Added 4.0%	270,685 $113 Million
Q4 2023 Feb 01, 2024	SELL	$343.0 - $410.68 $7.5 Million - $8.99 Million	-21,880 Reduced 7.75%	260,273 $106 Million
Q3 2023 Oct 19, 2023	SELL	$338.18 - $362.46 $1.28 Million - $1.37 Million	-3,780 Reduced 1.32%	282,153 $98.1 Million
Q2 2023 Aug 02, 2023	SELL	$314.42 - $351.91 $15.7 Million - $17.6 Million	-49,918 Reduced 14.86%	285,933 $101 Million
Q1 2023 Apr 28, 2023	BUY	$283.23 - $323.1 $1.44 Million - $1.64 Million	5,090 Added 1.54%	335,851 $106 Million
Q4 2022 Feb 07, 2023	SELL	$285.76 - $321.48 $7.45 Million - $8.38 Million	-26,056 Reduced 7.3%	330,761 $95.5 Million
Q3 2022 Oct 27, 2022	BUY	$273.83 - $305.53 $1.74 Million - $1.94 Million	6,361 Added 1.82%	356,817 $103 Million
Q2 2022 Aug 03, 2022	BUY	$234.96 - $292.55 $33.5 Million - $41.7 Million	142,575 Added 68.58%	350,456 $98.8 Million
Q1 2022 May 11, 2022	BUY	$221.42 - $260.97 $3.06 Million - $3.61 Million	13,837 Added 7.13%	207,881 $54.3 Million
Q4 2021 Feb 08, 2022	BUY	$177.01 - $223.45 $21.5 Million - $27.2 Million	121,656 Added 168.06%	194,044 $42.6 Million
Q3 2021 Nov 10, 2021	SELL	$181.39 - $202.99 $7.19 Million - $8.05 Million	-39,633 Reduced 35.38%	72,388 $13.1 Million
Q2 2021 Aug 03, 2021	SELL	$187.49 - $221.1 $17.7 Million - $20.9 Million	-94,556 Reduced 45.77%	112,021 $22.6 Million
Q1 2021 Apr 29, 2021	BUY	$207.02 - $241.31 $739,268 - $861,718	3,571 Added 1.76%	206,577 $44.4 Million
Q4 2020 Feb 11, 2021	BUY	$207.01 - $276.09 $5.37 Million - $7.16 Million	25,944 Added 14.65%	203,006 $48 Million
Q3 2020 Nov 13, 2020	SELL	$255.65 - $303.1 $1.54 Million - $1.82 Million	-6,020 Reduced 3.29%	177,062 $48.2 Million
Q2 2020 Aug 13, 2020	BUY	$225.48 - $295.8 $12.5 Million - $16.4 Million	55,374 Added 43.36%	183,082 $53.2 Million
Q1 2020 May 14, 2020	SELL	$199.77 - $247.81 $2 Million - $2.48 Million	-10,000 Reduced 7.26%	127,708 $30.4 Million
Q4 2019 Feb 14, 2020	BUY	$166.71 - $223.91 $3.62 Million - $4.86 Million	21,708 Added 18.71%	137,708 $30.2 Million
Q3 2019 Oct 31, 2019	BUY	$166.23 - $187.09 $2.49 Million - $2.81 Million	15,000 Added 14.85%	116,000 $19.7 Million
Q2 2019 Jul 12, 2019	BUY	$164.61 - $190.37 $4.44 Million - $5.14 Million	27,000 Added 36.49%	101,000 $18.5 Million
Q1 2019 May 10, 2019	SELL	$163.73 - $194.7 $2.46 Million - $2.92 Million	-15,000 Reduced 16.85%	74,000 $13.6 Million
Q4 2018 Jan 31, 2019	BUY	$151.91 - $192.21 $1.22 Million - $1.54 Million	8,000 Added 9.88%	89,000 $14.7 Million
Q3 2018 Oct 19, 2018	BUY	$167.73 - $192.74 $4.03 Million - $4.63 Million	24,000 Added 42.11%	81,000 $15.6 Million
Q2 2018 Jul 11, 2018	BUY	$145.72 - $169.96 $2.19 Million - $2.55 Million	15,000 Added 35.71%	57,000 $9.69 Million
Q1 2018 May 21, 2018	BUY	$151.6 - $177.13 $6.37 Million - $7.44 Million	42,000 New	42,000 $6.85 Million
Q1 2018 May 18, 2018	SELL	$151.6 - $177.13 $5.08 Million - $5.93 Million	-33,500 Closed	0 $0
Q4 2017 Feb 08, 2018	BUY	$137.28 - $155.55 $1.99 Million - $2.26 Million	14,500 Added 76.32%	33,500 $5.02 Million
Q3 2017 Oct 24, 2017	BUY	$148.13 - $162.24 $2.81 Million - $3.08 Million	19,000	19,000 $2.89 Million

Others Institutions Holding VRTX

# of Institutions

1,716

Shares Held

225M

Call Options Held

1.19M

Put Options Held

1.56M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Handelsbanken Fonder Ab, based on Form 13F filings with the SEC.

News

Stay updated on Handelsbanken Fonder Ab with notifications on news.

Account

Handelsbanken Fonder Ab Vertex Pharmaceuticals Inc Transaction History